ADVERTISEMENT
References
-
Barinka C, Rojas C, Slusher B, Pomper M. Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer. Current medicinal chemistry. 2012;19(6):856-870.
-
Chang SS. Overview of prostate-specific membrane antigen. Reviews in urology. 2004;6(Suppl 10):S13.
-
Conway RE, Petrovic N, Li Z, et al. Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction. Molecular and cellular biology. 2006;26(14):5310-5324.
-
Schreiber H, Nimphius W, Verbürg F, et al. Prostate specific membrane antigen (PSMA) expression in transitional cell carcinoma (TCC)–who puts the S in PSMA? European Urology Supplements. 2018;17(2):e863.
-
Tolkach Y, Gevensleben H, Bundschuh R, et al. Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy. Breast cancer research and treatment. 2018;169(3):447-455.
-
Abdel-Hadi M, Ismail Y, Younis L. Prostate-specific membrane antigen (PSMA) immunoexpression in the neovasculature of colorectal carcinoma in Egyptian patients. Pathology-Research and Practice. 2014;210(11):759-763.
-
Sweat SD, Pacelli A, Murphy GP, Bostwick DG. Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology. 1998;52(4):637-40.
-
Baccala A, Sercia L, Li J, et al. Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms. Urology. 2007;70(2):385-390.
-
Chang SS, Reuter VE, Heston WD, Gaudin PB. Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen. Urology. 2001;57(4):801-805.
